BRAF and melanoma: Inhibition of EZH2 with the specific inhibitor EPZ-6438 (EPZ) significantly increased miR-129-5p expression in BRAF mutated melanoma cell lines (A375, WM35), even in BRAFi resistant cell lines (A375R, WM35R).